Steve Schonfeld’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
Other funds holding KYMR
BBA
Steve Schonfeld's KYMR Position: Q3 2026 in Review
Steve Schonfeld opened a new position in Kymera Therapeutics (KYMR) in Q3 2026: 7,835 shares worth $876K. The stake represents ﹤0.01% of the portfolio and ranks #1683 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in KYMR as recently as Q1 2026.
Steve Schonfeld first reported a position in KYMR in Q3 2020 and has held it in 12 quarters since. The position peaked at $15.3M in Q1 2024. 301 funds tracked by Wall St. Rank hold KYMR as of Q3 2026.
- Steve Schonfeld held 7,835 shares of Kymera Therapeutics worth $876K as of Q3 2026.
- Kymera Therapeutics was a new Steve Schonfeld position in Q3 2026.
- Kymera Therapeutics made up ﹤0.01% of Steve Schonfeld's portfolio in Q3 2026, its #1683 holding.
- Steve Schonfeld first reported a position in Kymera Therapeutics in Q3 2020 and has held it in 12 quarters since.
- Steve Schonfeld's Kymera Therapeutics position peaked at $15.3M in Q1 2024.
- 301 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.